中文版 | English
题名

Modified metabolites mapping by liquid chromatography-high resolution mass spectrometry using full scan/all ion Cheek for fragmentation/neutral loss acquisition

作者
通讯作者Shi, Xianzhe
发表日期
2019-01-04
DOI
发表期刊
ISSN
0021-9673
EISSN
1873-3778
卷号1583页码:80-87
摘要
Modified metabolites play important roles in diagnostic monitoring, oxidative response and physiological regulation. Comprehensive analytical methods are greatly needed for improving the coverage of modified metabolites and studying their physiological function. Here, a novel nontargeted profiling method for mapping modified metabolites was developed by liquid chromatography-high resolution mass spectrometry with full scan/all ion fragmentation/neutral loss (FS/AIF/NL) data acquisition. Modified metabolites were unbiasedly defined with less false positive results by mixed standards verification. Thirteen types of modified metabolites in urine were analyzed at the same time, and 198 of 307 modified metabolites at positive mode and 166 of 366 modified metabolites at negative mode were putatively identified. The modified metabolites profiling method was applied for investigating the metabolic differences between the patients with breast cancer and health controls. As a result, many modified metabolites with glu-curonidation, ribosylation and indole acetylation modification were significantly up-regulated in breast cancer and four modified metabolites including 7-methylguanosine, N-4-acetylcytidine, dihyroxy-1H-indole glucuronide I and indole-3-acetic acid-O-glucuronide were identified as potential biomarkers for the diagnose of breast cancer. (C) 2018 Elsevier B.V. All rights reserved.
关键词
相关链接[来源记录]
收录类别
SCI ; EI
语种
英语
学校署名
第一
资助项目
National Natural Science Foundation of China[21575142] ; National Natural Science Foundation of China[21505132] ; National Natural Science Foundation of China[21705147] ; National Natural Science Foundation of China[21435006]
WOS研究方向
Biochemistry & Molecular Biology ; Chemistry
WOS类目
Biochemical Research Methods ; Chemistry, Analytical
WOS记录号
WOS:000455692100010
出版者
EI入藏号
20184706128550
EI主题词
Acetylation ; Data acquisition ; Diagnosis ; Diseases ; Ions ; Liquid chromatography ; Mapping ; Mass spectrometry ; Metabolites ; Physiological models ; Physiology ; Polycyclic aromatic hydrocarbons
EI分类号
Surveying:405.3 ; Medicine and Pharmacology:461.6 ; Biology:461.9 ; Data Processing and Image Processing:723.2 ; Chemistry:801 ; Chemical Reactions:802.2 ; Organic Compounds:804.1
ESI学科分类
CHEMISTRY
来源库
Web of Science
引用统计
被引频次[WOS]:32
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/26635
专题公共分析测试中心
作者单位
1.Southern Univ Sci & Technol, Mat Characterizat & Preparat Ctr, Shenzhen 518055, Peoples R China
2.Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China
3.Shekou Peoples Hosp, Dept clin lab, Shenzhen 518052, Peoples R China
4.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
第一作者单位公共分析测试中心
第一作者的第一单位公共分析测试中心
推荐引用方式
GB/T 7714
Li, Hua,Qin, Qian,Shi, Xianzhe,et al. Modified metabolites mapping by liquid chromatography-high resolution mass spectrometry using full scan/all ion Cheek for fragmentation/neutral loss acquisition[J]. JOURNAL OF CHROMATOGRAPHY A,2019,1583:80-87.
APA
Li, Hua,Qin, Qian,Shi, Xianzhe,He, Jun,&Xu, Guowang.(2019).Modified metabolites mapping by liquid chromatography-high resolution mass spectrometry using full scan/all ion Cheek for fragmentation/neutral loss acquisition.JOURNAL OF CHROMATOGRAPHY A,1583,80-87.
MLA
Li, Hua,et al."Modified metabolites mapping by liquid chromatography-high resolution mass spectrometry using full scan/all ion Cheek for fragmentation/neutral loss acquisition".JOURNAL OF CHROMATOGRAPHY A 1583(2019):80-87.
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Li, Hua]的文章
[Qin, Qian]的文章
[Shi, Xianzhe]的文章
百度学术
百度学术中相似的文章
[Li, Hua]的文章
[Qin, Qian]的文章
[Shi, Xianzhe]的文章
必应学术
必应学术中相似的文章
[Li, Hua]的文章
[Qin, Qian]的文章
[Shi, Xianzhe]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。